SARGON IMMEDIATE LOAD IMPLANT, MODEL D
Device Facts
| Record ID | K981141 |
|---|---|
| Device Name | SARGON IMMEDIATE LOAD IMPLANT, MODEL D |
| Applicant | Sargon Ent., Inc. |
| Product Code | DZE · Dental |
| Decision Date | Jun 23, 1999 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 872.3640 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
For immediate load use, without an abutment, in either partially or fully edentulous mandibles and maxillae, for fixed or detachable prosthesis and for use in support of free-standing restorations with or without the involvement of adjacent dentition.
Device Story
Endosseous dental implant; used for prosthetic attachment in partially or fully edentulous mandibles and maxillae. Features longer collar design allowing direct fixation of prosthesis to implant, with or without abutment. Implanted by dental professionals in clinical settings. Provides structural support for fixed or detachable dental restorations; enables immediate loading. Benefits patient by facilitating dental reconstruction.
Clinical Evidence
No clinical data provided; substantial equivalence based on design comparison and material specifications.
Technological Characteristics
Endosseous dental implant; material: titanium 6Al-4V alloy (ASTM F136). Features longer collar design for direct prosthesis fixation. Mechanical device; no energy source or software.
Indications for Use
Indicated for patients with partially or fully edentulous mandibles and maxillae requiring fixed or detachable dental prostheses or support for free-standing restorations, with or without adjacent dentition involvement.
Regulatory Classification
Identification
An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.
Special Controls
*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.